|
Market Closed -
Euronext Bruxelles
18:55:00 31/08/2026 +03
|
After hours 19:39:11 | |||
| 215.30 EUR | -0.55% |
|
214.90 | -0.19% |
| 08-20 | Cancer vaccines finally garner the spotlight |  |
| 08-19 | Danish Pharma H. Lundbeck Expects No Slowdown for Primary Growth Driver Brands | MT |
Chart: Technical Analysis
Stock exchange
Euronext Bruxelles
UCB 215.30 €
-0.55%
67.21M
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Euronext Bruxelles
| UCB | 215.30EUR | -0.55% | 67.21M € | |
CBOE
| UCB | 214.50EUR | -0.88% | 10.1M € | |
|
Xetra
| UNC | 211.90EUR | -5.19% | 30.51K € | |
|
Tradegate
| UNC | 214.70EUR | -0.69% | 29.84K € | |
|
CBOE
| 0NZT | 214.80EUR | -0.74% | 14.39K € | |
|
Börse Stuttgart
| UNC | 214.90EUR | -0.60% | 9.67K € | |
|
Boerse Muenchen
| UNC | 214.90EUR | -0.78% | 3.01K € | |
|
London S.E.
| 0NZT | 216.45EUR | -2.65% | 432.9 € | |
|
Deutsche Boerse AG
| UNC | 215.90EUR | -2.79% | 0 € | |
|
Wiener Boerse
| UCB | 217.70EUR | -1.40% | 0 € | |
|
Borsa Italiana
| 4UCB | 216.40EUR | -2.70% | 0 € | |
OTC Markets
| UCBJY | 150.93USD | +3.45% | 344K $ | |
|
Deutsche Boerse AG
| UNC0 | 108.00EUR | -2.70% | 0 € | |
|
Börse Stuttgart
| UNC0 | 107.00EUR | -0.93% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 229.2 | 247.6 | 279.5 |
| Spread/Res. | -6.06% | -13.05% | -22.97% |
| Spread/Supp. | +1.41% | +1.41% | +9.34% |
| Support | 212.3 | 212.3 | 196.9 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- UCB Stock
- Charts UCB
Select your edition
All financial news and data tailored to specific country editions
